Amplifon shares moved lower on Thursday, down roughly 4.5% to trade at €11.66 from the prior session's close of €12.215, following a weaker-than-expected quarterly update from GN Store Nord. Amplifon had agreed in March to acquire GN Store Nord's hearing arm, GN Hearing, and the Danish group's subdued second-quarter performance and trimmed guidance have heightened near-term investor caution.
GN Store Nord revised its full-year 2026 organic sales growth guidance down to a range of 0-3% from an earlier 0-6% range. Management cited softer assumptions for its gaming and enterprise divisions, shifting expected outcomes toward the lower end of previously assumed ranges.
Within GN Store Nord's hearing division, organic sales decreased 2%. Jefferies analysts pointed to a challenging year-over-year comparison as a factor, describing the period as "the toughest comparative base of the year." The division also registered a 25% year-on-year decline in EBITDA, a deterioration the company attributed in part to lower volumes with a U.S. client.
Amplifon's recent rally from its 52-week low of €7.836, reached in March 2026, helps explain its present sensitivity to fresh negative news. The stock had been buoyed by a strong first-half 2026 earnings release on July 30, which reported 4.7% organic revenue growth - the highest rate in two years - and an adjusted net profit increase of 12.3%. Those results had supported a notable recovery in the shares ahead of this week's reversal.
On the wider market front, global gauges offered little directional lift. The S&P 500 and the Dow Jones were essentially unchanged in early trading, leaving European equities without an external positive impulse. Italy's FTSE MIB, the domestic benchmark relevant for Amplifon, likewise did not provide a meaningful supportive backdrop.
Investors are also weighing Amplifon's simultaneous tasks: absorbing GN Hearing and advancing its Fit4Growth restructuring program. Both initiatives continue to influence near-term sentiment, creating potential headwinds until integration progress and restructuring outcomes become clearer.
Overall, the pullback in Amplifon reflects the direct impact of GN Store Nord's weaker Q2 showing and the lowered FY26 outlook for organic sales, combined with a market environment that fails to counterbalance those developments.